CN Patent

CN111787954B — 使用莫美他松和奥洛他定的组合治疗儿科受试者的过敏性鼻炎

Assigned to Glenmark Specialty SA · Expires 2023-09-05 · 3y expired

What this patent protects

本发明涉及一种在有需要的儿科受试者中治疗过敏性鼻炎的方法，其包括向所述受试者经鼻施用有效量的包含莫美他松或其盐和奥洛他定或其盐的固定剂量药物组合物。

USPTO Abstract

本发明涉及一种在有需要的儿科受试者中治疗过敏性鼻炎的方法，其包括向所述受试者经鼻施用有效量的包含莫美他松或其盐和奥洛他定或其盐的固定剂量药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111787954B
Jurisdiction
CN
Classification
—
Expires
2023-09-05
Drug substance claim
No
Drug product claim
No
Assignee
Glenmark Specialty SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.